Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cataract Extraction | 9 | 2016 | 481 | 1.870 |
Why?
|
Genes, BRCA1 | 32 | 2012 | 781 | 1.850 |
Why?
|
Genes, BRCA2 | 29 | 2012 | 618 | 1.610 |
Why?
|
United States Department of Veterans Affairs | 7 | 2016 | 875 | 1.190 |
Why?
|
Phacoemulsification | 4 | 2017 | 149 | 1.190 |
Why?
|
Ovarian Neoplasms | 32 | 2013 | 4839 | 1.160 |
Why?
|
Visual Acuity | 6 | 2017 | 2530 | 1.100 |
Why?
|
Capsulorhexis | 3 | 2016 | 15 | 1.060 |
Why?
|
BRCA1 Protein | 15 | 2013 | 1149 | 1.000 |
Why?
|
BRCA2 Protein | 16 | 2013 | 794 | 0.990 |
Why?
|
Eye Foreign Bodies | 3 | 2017 | 55 | 0.960 |
Why?
|
Ovariectomy | 14 | 2010 | 661 | 0.900 |
Why?
|
Breast Neoplasms | 53 | 2013 | 20824 | 0.830 |
Why?
|
Eye | 3 | 2022 | 729 | 0.800 |
Why?
|
Ophthalmology | 3 | 2017 | 508 | 0.780 |
Why?
|
Cataract | 5 | 2016 | 834 | 0.680 |
Why?
|
Ophthalmoscopes | 1 | 2017 | 23 | 0.620 |
Why?
|
Nematode Infections | 1 | 2017 | 22 | 0.600 |
Why?
|
Eye Infections, Parasitic | 1 | 2017 | 24 | 0.590 |
Why?
|
Insect Bites and Stings | 1 | 2017 | 67 | 0.560 |
Why?
|
Tear Gases | 1 | 2016 | 6 | 0.560 |
Why?
|
Tremor | 1 | 2017 | 175 | 0.560 |
Why?
|
Quality of Life | 7 | 2017 | 12802 | 0.550 |
Why?
|
Conjunctival Diseases | 1 | 2017 | 122 | 0.540 |
Why?
|
Exfoliation Syndrome | 1 | 2016 | 110 | 0.530 |
Why?
|
Clinical Competence | 5 | 2017 | 4687 | 0.530 |
Why?
|
Veterans Health | 2 | 2017 | 216 | 0.510 |
Why?
|
Genetic Predisposition to Disease | 34 | 2013 | 17446 | 0.480 |
Why?
|
Intraocular Pressure | 2 | 2016 | 1270 | 0.470 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2017 | 349 | 0.460 |
Why?
|
Eye Injuries | 2 | 2016 | 245 | 0.450 |
Why?
|
Motor Skills | 1 | 2016 | 522 | 0.430 |
Why?
|
Computer Simulation | 3 | 2017 | 6194 | 0.420 |
Why?
|
Cysts | 1 | 2017 | 678 | 0.400 |
Why?
|
Microsurgery | 1 | 2017 | 796 | 0.400 |
Why?
|
Internship and Residency | 3 | 2017 | 5791 | 0.390 |
Why?
|
Intraoperative Complications | 5 | 2016 | 1198 | 0.380 |
Why?
|
User-Computer Interface | 1 | 2017 | 1431 | 0.370 |
Why?
|
Iris Diseases | 3 | 2014 | 40 | 0.360 |
Why?
|
Cornea | 2 | 2017 | 1524 | 0.350 |
Why?
|
Functional Laterality | 2 | 2016 | 2290 | 0.340 |
Why?
|
Postoperative Complications | 5 | 2016 | 15297 | 0.340 |
Why?
|
Lens Implantation, Intraocular | 3 | 2017 | 192 | 0.330 |
Why?
|
Heterozygote | 16 | 2013 | 2804 | 0.330 |
Why?
|
Glaucoma | 2 | 2015 | 1159 | 0.310 |
Why?
|
Genetic Counseling | 6 | 2011 | 600 | 0.310 |
Why?
|
Ovary | 4 | 2009 | 981 | 0.310 |
Why?
|
Glucocorticoids | 1 | 2017 | 2108 | 0.300 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2007 | 129 | 0.280 |
Why?
|
Educational Measurement | 1 | 2013 | 1210 | 0.280 |
Why?
|
Mutation | 23 | 2022 | 29786 | 0.270 |
Why?
|
Soy Foods | 1 | 2005 | 48 | 0.260 |
Why?
|
Germ-Line Mutation | 14 | 2012 | 1788 | 0.260 |
Why?
|
Soybean Proteins | 1 | 2005 | 61 | 0.260 |
Why?
|
Needles | 1 | 2008 | 449 | 0.260 |
Why?
|
Body Fluids | 1 | 2007 | 319 | 0.260 |
Why?
|
Nipples | 1 | 2007 | 219 | 0.260 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 2291 | 0.260 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 642 | 0.250 |
Why?
|
Nutritional Sciences | 1 | 2005 | 137 | 0.240 |
Why?
|
Acid Anhydride Hydrolases | 3 | 2009 | 72 | 0.230 |
Why?
|
Corneal Diseases | 1 | 2010 | 636 | 0.220 |
Why?
|
Biopsy, Fine-Needle | 2 | 2009 | 1094 | 0.220 |
Why?
|
Informed Consent | 3 | 2011 | 995 | 0.210 |
Why?
|
Perioperative Care | 1 | 2010 | 1002 | 0.210 |
Why?
|
Primary Prevention | 3 | 2010 | 1167 | 0.200 |
Why?
|
Jews | 4 | 2012 | 385 | 0.190 |
Why?
|
Humans | 98 | 2022 | 744366 | 0.190 |
Why?
|
Quality of Health Care | 1 | 2016 | 4369 | 0.180 |
Why?
|
Genetic Testing | 8 | 2012 | 3444 | 0.180 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2012 | 367 | 0.180 |
Why?
|
Attitude to Health | 3 | 2011 | 2052 | 0.180 |
Why?
|
Female | 80 | 2017 | 380193 | 0.180 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19905 | 0.180 |
Why?
|
CA-125 Antigen | 2 | 2012 | 286 | 0.170 |
Why?
|
Databases, Factual | 4 | 2015 | 7730 | 0.170 |
Why?
|
Breast | 2 | 2011 | 1970 | 0.170 |
Why?
|
Orbit | 1 | 2022 | 426 | 0.160 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7182 | 0.160 |
Why?
|
Risk Factors | 34 | 2014 | 72296 | 0.160 |
Why?
|
Patient Selection | 2 | 2010 | 4216 | 0.160 |
Why?
|
Sickness Impact Profile | 2 | 2017 | 302 | 0.160 |
Why?
|
Middle Aged | 52 | 2017 | 213390 | 0.150 |
Why?
|
Patient Education as Topic | 4 | 2011 | 2278 | 0.150 |
Why?
|
Receptors, Estrogen | 6 | 2012 | 2190 | 0.150 |
Why?
|
Pseudophakia | 1 | 2017 | 62 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 14 | 2013 | 15520 | 0.150 |
Why?
|
Disclosure | 1 | 2003 | 736 | 0.150 |
Why?
|
Prospective Studies | 16 | 2017 | 53290 | 0.150 |
Why?
|
Adult | 50 | 2022 | 214052 | 0.140 |
Why?
|
Risk Reduction Behavior | 5 | 2012 | 1125 | 0.140 |
Why?
|
Haplotypes | 4 | 2011 | 2779 | 0.140 |
Why?
|
Feeding Behavior | 2 | 2007 | 3188 | 0.140 |
Why?
|
Eye Diseases | 1 | 2022 | 669 | 0.140 |
Why?
|
Administration, Topical | 2 | 2017 | 690 | 0.140 |
Why?
|
Vision Disorders | 2 | 2015 | 1058 | 0.140 |
Why?
|
United States | 15 | 2017 | 69872 | 0.140 |
Why?
|
Mammography | 4 | 2009 | 2475 | 0.130 |
Why?
|
Aged | 39 | 2017 | 163288 | 0.130 |
Why?
|
Mastectomy | 3 | 2010 | 1793 | 0.130 |
Why?
|
Registries | 6 | 2011 | 8091 | 0.120 |
Why?
|
Introns | 2 | 2008 | 992 | 0.120 |
Why?
|
Acetyltransferases | 2 | 2006 | 234 | 0.120 |
Why?
|
Medicare | 1 | 2012 | 6566 | 0.120 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2012 | 484 | 0.120 |
Why?
|
Family | 3 | 2010 | 3147 | 0.120 |
Why?
|
Genotype | 12 | 2013 | 12952 | 0.120 |
Why?
|
Salpingostomy | 2 | 2010 | 11 | 0.120 |
Why?
|
Mass Screening | 5 | 2010 | 5253 | 0.120 |
Why?
|
Motivation | 1 | 2003 | 1971 | 0.120 |
Why?
|
Lens Capsule, Crystalline | 2 | 2014 | 43 | 0.110 |
Why?
|
Anterior Eye Segment | 2 | 2011 | 152 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 4 | 2011 | 2850 | 0.110 |
Why?
|
Risk Assessment | 13 | 2012 | 23336 | 0.110 |
Why?
|
Rad51 Recombinase | 2 | 2011 | 189 | 0.110 |
Why?
|
Ointments | 1 | 2011 | 59 | 0.100 |
Why?
|
Vision, Ocular | 1 | 2015 | 464 | 0.100 |
Why?
|
Pamphlets | 1 | 2011 | 75 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2029 | 0.100 |
Why?
|
Gene Frequency | 5 | 2010 | 3587 | 0.100 |
Why?
|
Polychondritis, Relapsing | 1 | 2011 | 28 | 0.100 |
Why?
|
Oncogene Proteins | 2 | 2006 | 749 | 0.100 |
Why?
|
DNA Mutational Analysis | 7 | 2008 | 4185 | 0.100 |
Why?
|
Risk | 11 | 2011 | 9688 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2010 | 188 | 0.090 |
Why?
|
Breast Self-Examination | 1 | 2010 | 34 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2012 | 9647 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 365 | 0.090 |
Why?
|
Retrospective Studies | 9 | 2016 | 77460 | 0.090 |
Why?
|
Videotape Recording | 1 | 2011 | 352 | 0.090 |
Why?
|
Male | 21 | 2022 | 350115 | 0.090 |
Why?
|
Nursing Assessment | 1 | 2010 | 107 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2003 | 3020 | 0.090 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2011 | 272 | 0.090 |
Why?
|
Models, Anatomic | 1 | 2013 | 691 | 0.090 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2007 | 9240 | 0.090 |
Why?
|
Trypan Blue | 1 | 2009 | 21 | 0.090 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2010 | 114 | 0.090 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2010 | 111 | 0.090 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2009 | 100 | 0.080 |
Why?
|
Receptors, Progesterone | 2 | 2010 | 1098 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2011 | 457 | 0.080 |
Why?
|
Genetic Linkage | 3 | 2005 | 2421 | 0.080 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 535 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3464 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6489 | 0.080 |
Why?
|
RNA Helicases | 1 | 2009 | 142 | 0.080 |
Why?
|
Diet | 1 | 2007 | 7937 | 0.080 |
Why?
|
Neoplasm Proteins | 3 | 2008 | 3707 | 0.080 |
Why?
|
Video Recording | 1 | 2013 | 949 | 0.080 |
Why?
|
Videoconferencing | 1 | 2010 | 195 | 0.080 |
Why?
|
Somatomedins | 1 | 2009 | 192 | 0.080 |
Why?
|
Comprehension | 2 | 2011 | 610 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2009 | 326 | 0.080 |
Why?
|
Cell Polarity | 1 | 2011 | 645 | 0.080 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2008 | 58 | 0.080 |
Why?
|
Endodeoxyribonucleases | 1 | 2009 | 165 | 0.080 |
Why?
|
Elastic Modulus | 1 | 2009 | 214 | 0.080 |
Why?
|
Trans-Activators | 3 | 2010 | 2926 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2011 | 3922 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 216 | 0.080 |
Why?
|
Allelic Imbalance | 1 | 2008 | 77 | 0.080 |
Why?
|
Truth Disclosure | 1 | 2012 | 436 | 0.080 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2009 | 460 | 0.080 |
Why?
|
Macular Degeneration | 1 | 2015 | 980 | 0.080 |
Why?
|
Macular Edema | 1 | 2011 | 359 | 0.080 |
Why?
|
DNA Repair Enzymes | 1 | 2009 | 349 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2011 | 850 | 0.070 |
Why?
|
Endophthalmitis | 1 | 2010 | 262 | 0.070 |
Why?
|
Parent-Child Relations | 1 | 2012 | 747 | 0.070 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2010 | 324 | 0.070 |
Why?
|
Precancerous Conditions | 3 | 2006 | 975 | 0.070 |
Why?
|
Women's Health | 2 | 2007 | 2034 | 0.070 |
Why?
|
Deafness | 1 | 2011 | 458 | 0.070 |
Why?
|
Breast Neoplasms, Male | 2 | 2006 | 210 | 0.070 |
Why?
|
Operating Rooms | 1 | 2013 | 817 | 0.070 |
Why?
|
Alleles | 4 | 2011 | 6933 | 0.070 |
Why?
|
Speech | 1 | 2011 | 541 | 0.070 |
Why?
|
Case-Control Studies | 14 | 2011 | 21748 | 0.070 |
Why?
|
Logistic Models | 5 | 2015 | 13409 | 0.070 |
Why?
|
Coloring Agents | 1 | 2009 | 566 | 0.070 |
Why?
|
Basement Membrane | 2 | 2004 | 357 | 0.070 |
Why?
|
Transcription Factors | 4 | 2012 | 12207 | 0.070 |
Why?
|
Retinal Detachment | 1 | 2010 | 411 | 0.070 |
Why?
|
Corneal Transplantation | 1 | 2010 | 386 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2011 | 1073 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2015 | 12244 | 0.070 |
Why?
|
Food, Organic | 1 | 2005 | 34 | 0.070 |
Why?
|
Genome-Wide Association Study | 4 | 2013 | 12262 | 0.070 |
Why?
|
Arthritis | 1 | 2011 | 661 | 0.070 |
Why?
|
Data Collection | 2 | 2007 | 3339 | 0.070 |
Why?
|
Anxiety | 1 | 1999 | 4293 | 0.060 |
Why?
|
Linkage Disequilibrium | 4 | 2011 | 1997 | 0.060 |
Why?
|
Genetic Variation | 5 | 2011 | 6542 | 0.060 |
Why?
|
Students, Medical | 1 | 2017 | 1862 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2017 | 2657 | 0.060 |
Why?
|
Age Factors | 8 | 2012 | 18373 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2015 | 57776 | 0.060 |
Why?
|
Hormone Replacement Therapy | 2 | 2010 | 745 | 0.060 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.060 |
Why?
|
Body Image | 1 | 2009 | 610 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1152 | 0.060 |
Why?
|
Aftercare | 1 | 2010 | 870 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 3 | 2004 | 1097 | 0.060 |
Why?
|
Selection, Genetic | 1 | 2008 | 914 | 0.060 |
Why?
|
Carcinoma | 2 | 2010 | 2375 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2010 | 2110 | 0.060 |
Why?
|
Receptor, erbB-2 | 2 | 2010 | 2417 | 0.060 |
Why?
|
Ovarian Cysts | 1 | 2003 | 115 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2760 | 0.050 |
Why?
|
Diclofenac | 1 | 2003 | 71 | 0.050 |
Why?
|
Medical History Taking | 1 | 2007 | 784 | 0.050 |
Why?
|
Ketorolac | 1 | 2003 | 79 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8319 | 0.050 |
Why?
|
Gonadotropins | 1 | 2004 | 241 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3605 | 0.050 |
Why?
|
North America | 4 | 2010 | 1249 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2009 | 1862 | 0.050 |
Why?
|
Prognosis | 8 | 2013 | 29060 | 0.050 |
Why?
|
Decision Making | 5 | 2011 | 3888 | 0.050 |
Why?
|
Postmenopause | 2 | 2011 | 2460 | 0.050 |
Why?
|
Educational Status | 2 | 2011 | 2540 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10637 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2004 | 468 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2003 | 315 | 0.050 |
Why?
|
Postoperative Care | 1 | 2008 | 1487 | 0.050 |
Why?
|
Trinucleotide Repeats | 2 | 2001 | 261 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39052 | 0.050 |
Why?
|
Veterans | 1 | 2015 | 2519 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12961 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2002 | 197 | 0.050 |
Why?
|
RNA Splicing | 1 | 2006 | 908 | 0.050 |
Why?
|
Diet Surveys | 1 | 2005 | 1173 | 0.050 |
Why?
|
Anticarcinogenic Agents | 1 | 2003 | 253 | 0.050 |
Why?
|
Polymorphism, Genetic | 3 | 2006 | 4328 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 3 | 3 | 2006 | 53 | 0.050 |
Why?
|
Matrix Metalloproteinases | 1 | 2003 | 391 | 0.050 |
Why?
|
Australia | 2 | 2002 | 1167 | 0.050 |
Why?
|
Reproductive History | 1 | 2001 | 209 | 0.050 |
Why?
|
Prostatic Neoplasms | 3 | 2008 | 11126 | 0.040 |
Why?
|
Fruit | 1 | 2005 | 1142 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1178 | 0.040 |
Why?
|
Incidence | 6 | 2012 | 20952 | 0.040 |
Why?
|
Vegetables | 1 | 2005 | 1182 | 0.040 |
Why?
|
Europe | 4 | 2010 | 3338 | 0.040 |
Why?
|
Founder Effect | 2 | 2011 | 189 | 0.040 |
Why?
|
Immunoenzyme Techniques | 3 | 2012 | 1799 | 0.040 |
Why?
|
Models, Psychological | 1 | 2003 | 811 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2007 | 1100 | 0.040 |
Why?
|
Sexual Behavior | 1 | 2009 | 2055 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1728 | 0.040 |
Why?
|
Medical Oncology | 1 | 2010 | 2267 | 0.040 |
Why?
|
Swine | 1 | 2008 | 5918 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3056 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2010 | 1157 | 0.040 |
Why?
|
Family Health | 1 | 2003 | 1281 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2011 | 5856 | 0.040 |
Why?
|
Age of Onset | 3 | 2011 | 3270 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2010 | 11031 | 0.040 |
Why?
|
Canada | 2 | 2000 | 2065 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 7023 | 0.040 |
Why?
|
Odds Ratio | 4 | 2014 | 9849 | 0.040 |
Why?
|
Proteins | 1 | 2012 | 6100 | 0.040 |
Why?
|
Ataxia Telangiectasia | 1 | 1978 | 112 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2003 | 7785 | 0.030 |
Why?
|
Peritoneal Neoplasms | 1 | 2002 | 665 | 0.030 |
Why?
|
Neoplasms | 4 | 2012 | 21696 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5023 | 0.030 |
Why?
|
Cohort Studies | 7 | 2017 | 40559 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3252 | 0.030 |
Why?
|
Confidentiality | 1 | 2000 | 612 | 0.030 |
Why?
|
Contraceptives, Oral | 2 | 2011 | 564 | 0.030 |
Why?
|
Health Promotion | 1 | 2007 | 2205 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2007 | 25039 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2003 | 6366 | 0.030 |
Why?
|
Prevalence | 4 | 2014 | 15221 | 0.030 |
Why?
|
Communication | 2 | 2012 | 3750 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2008 | 13035 | 0.030 |
Why?
|
Radiology | 1 | 2008 | 2099 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2007 | 15078 | 0.030 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 1 | 2014 | 24 | 0.030 |
Why?
|
Prolapse | 1 | 2014 | 68 | 0.030 |
Why?
|
Animals | 5 | 2017 | 168768 | 0.030 |
Why?
|
Proportional Hazards Models | 5 | 2012 | 12356 | 0.030 |
Why?
|
Histone Acetyltransferases | 2 | 2006 | 335 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2006 | 3966 | 0.030 |
Why?
|
Peptides | 1 | 2006 | 4410 | 0.030 |
Why?
|
International Cooperation | 1 | 2000 | 1420 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14723 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2011 | 4245 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2282 | 0.030 |
Why?
|
Preoperative Period | 1 | 2015 | 550 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 1999 | 1058 | 0.030 |
Why?
|
Age Distribution | 2 | 2012 | 2902 | 0.030 |
Why?
|
Models, Statistical | 1 | 2007 | 5101 | 0.030 |
Why?
|
Petrolatum | 1 | 2011 | 8 | 0.030 |
Why?
|
Affect | 1 | 1999 | 1475 | 0.020 |
Why?
|
Polymerase Chain Reaction | 3 | 2008 | 6171 | 0.020 |
Why?
|
Gonioscopy | 1 | 2011 | 157 | 0.020 |
Why?
|
Replication Protein A | 1 | 2011 | 52 | 0.020 |
Why?
|
Triamcinolone Acetonide | 1 | 2011 | 101 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2015 | 63107 | 0.020 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2010 | 32 | 0.020 |
Why?
|
Prednisolone | 1 | 2011 | 334 | 0.020 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2010 | 133 | 0.020 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2011 | 148 | 0.020 |
Why?
|
Epithelial Cells | 3 | 2011 | 3690 | 0.020 |
Why?
|
Mutation, Missense | 2 | 2011 | 2566 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5749 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2011 | 464 | 0.020 |
Why?
|
High Mobility Group Proteins | 1 | 2010 | 187 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 380 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 287 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1842 | 0.020 |
Why?
|
Fallopian Tubes | 1 | 2010 | 182 | 0.020 |
Why?
|
Depression | 1 | 2009 | 7759 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 684 | 0.020 |
Why?
|
Penetrance | 1 | 2010 | 381 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 658 | 0.020 |
Why?
|
Smoking | 1 | 2005 | 8987 | 0.020 |
Why?
|
Fanconi Anemia | 1 | 2011 | 319 | 0.020 |
Why?
|
Delaware | 1 | 2008 | 16 | 0.020 |
Why?
|
Cognition | 2 | 2011 | 6770 | 0.020 |
Why?
|
Survival Analysis | 2 | 2012 | 10252 | 0.020 |
Why?
|
Isoleucine | 1 | 2007 | 112 | 0.020 |
Why?
|
Hawaii | 1 | 2007 | 105 | 0.020 |
Why?
|
Vesicular Transport Proteins | 1 | 2010 | 377 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2003 | 8432 | 0.020 |
Why?
|
Base Sequence | 2 | 2011 | 12797 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 1005 | 0.020 |
Why?
|
Premenopause | 1 | 2011 | 1033 | 0.020 |
Why?
|
Keratin-5 | 1 | 2007 | 46 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6364 | 0.020 |
Why?
|
Threonine | 1 | 2007 | 279 | 0.020 |
Why?
|
Histidine | 1 | 2007 | 313 | 0.020 |
Why?
|
Puromycin | 1 | 2006 | 44 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2009 | 563 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1525 | 0.020 |
Why?
|
Pennsylvania | 1 | 2008 | 613 | 0.020 |
Why?
|
Leucine | 1 | 2007 | 560 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.020 |
Why?
|
Proline | 1 | 2007 | 458 | 0.020 |
Why?
|
Microtubules | 1 | 2011 | 1089 | 0.020 |
Why?
|
Decision Trees | 1 | 2007 | 506 | 0.020 |
Why?
|
HeLa Cells | 1 | 2011 | 3130 | 0.020 |
Why?
|
Perception | 1 | 2012 | 1198 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2006 | 209 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2007 | 553 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2006 | 258 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2506 | 0.020 |
Why?
|
Choice Behavior | 1 | 2010 | 802 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2009 | 1101 | 0.020 |
Why?
|
Cell Line | 2 | 2011 | 16000 | 0.020 |
Why?
|
Genetics, Population | 1 | 2009 | 934 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2007 | 2050 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2715 | 0.010 |
Why?
|
Ultrasonography, Mammary | 1 | 2006 | 250 | 0.010 |
Why?
|
Texas | 1 | 1985 | 391 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 85779 | 0.010 |
Why?
|
Health Behavior | 1 | 1996 | 2635 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2003 | 104 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2006 | 798 | 0.010 |
Why?
|
Menopause | 1 | 2011 | 1626 | 0.010 |
Why?
|
Carboxymethylcellulose Sodium | 1 | 2003 | 39 | 0.010 |
Why?
|
Fenretinide | 1 | 2003 | 12 | 0.010 |
Why?
|
Collagen Type IV | 1 | 2003 | 140 | 0.010 |
Why?
|
Tyrosine | 1 | 2007 | 1462 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 802 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2006 | 640 | 0.010 |
Why?
|
Patient Participation | 1 | 2011 | 1457 | 0.010 |
Why?
|
Laminin | 1 | 2003 | 419 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5953 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2011 | 1418 | 0.010 |
Why?
|
Ophthalmic Solutions | 1 | 2003 | 317 | 0.010 |
Why?
|
Genetic Loci | 1 | 2011 | 2575 | 0.010 |
Why?
|
DNA Repair | 1 | 2011 | 2046 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2003 | 644 | 0.010 |
Why?
|
Carcinogens | 1 | 2004 | 466 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2003 | 1162 | 0.010 |
Why?
|
Lod Score | 1 | 2002 | 614 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3759 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 612 | 0.010 |
Why?
|
DNA Damage | 1 | 2011 | 2432 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5077 | 0.010 |
Why?
|
Pedigree | 1 | 2008 | 4642 | 0.010 |
Why?
|
Debridement | 1 | 2003 | 492 | 0.010 |
Why?
|
Epithelium, Corneal | 1 | 2003 | 247 | 0.010 |
Why?
|
Young Adult | 3 | 2012 | 56429 | 0.010 |
Why?
|
Cause of Death | 1 | 2010 | 3582 | 0.010 |
Why?
|
Family Characteristics | 1 | 2004 | 1000 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2004 | 1677 | 0.010 |
Why?
|
Sex Distribution | 1 | 2004 | 2297 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2004 | 1758 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2542 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2004 | 1276 | 0.010 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2002 | 450 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2010 | 3395 | 0.010 |
Why?
|
Parents | 1 | 2012 | 3405 | 0.010 |
Why?
|
Genome, Human | 1 | 2011 | 4420 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6896 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1985 | 2924 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2004 | 1504 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1996 | 335 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5984 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4740 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 13991 | 0.010 |
Why?
|
Gallbladder Neoplasms | 1 | 1978 | 182 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5181 | 0.010 |
Why?
|
Keratins | 1 | 1996 | 515 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16690 | 0.010 |
Why?
|
Phenotype | 2 | 2007 | 16367 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2003 | 2943 | 0.010 |
Why?
|
Population Surveillance | 1 | 2004 | 2616 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2003 | 2917 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12788 | 0.010 |
Why?
|
Demography | 1 | 1978 | 1655 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 1999 | 1203 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3511 | 0.010 |
Why?
|
Bile Duct Neoplasms | 1 | 1978 | 567 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9445 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2785 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13882 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81201 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8664 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1996 | 3616 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 1978 | 1332 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2003 | 7882 | 0.000 |
Why?
|
Rats | 1 | 2003 | 24252 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2003 | 9955 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2004 | 18034 | 0.000 |
Why?
|
Child | 1 | 2012 | 77709 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11525 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35425 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 1978 | 4253 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13693 | 0.000 |
Why?
|
Time Factors | 1 | 1999 | 40075 | 0.000 |
Why?
|
Signal Transduction | 1 | 1999 | 23404 | 0.000 |
Why?
|